Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran

Abstract Background: MMP9, as a member of the MMPs family, codes a protein that is able to provide suitable infrastructures for the migration of cancer cells and angiogenesis within tumor. The aim of this study was to investigate the relationship between -1562 C> T polymorphism in MMP9 promoter...

Full description

Bibliographic Details
Main Authors: Fatemeh Toroghi, Farhad Mashayekhi, Vahid Montazeri, Hamid Saeedi Saedi
Format: Article
Language:fas
Published: Arak Medical University 2016-06-01
Series:Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
Subjects:
Online Access:http://amuj.arakmu.ac.ir/article-1-4062-en.pdf
_version_ 1818157702782648320
author Fatemeh Toroghi
Farhad Mashayekhi
Vahid Montazeri
Hamid Saeedi Saedi
author_facet Fatemeh Toroghi
Farhad Mashayekhi
Vahid Montazeri
Hamid Saeedi Saedi
author_sort Fatemeh Toroghi
collection DOAJ
description Abstract Background: MMP9, as a member of the MMPs family, codes a protein that is able to provide suitable infrastructures for the migration of cancer cells and angiogenesis within tumor. The aim of this study was to investigate the relationship between -1562 C> T polymorphism in MMP9 promoter and progression of breast cancer in northwest of Iran. Materials and Methods: In this case-control study, 187 females from northwest of Iran were involved. Polymorphism of interest was determined by PCR-RFLP method using enzyme PaeI and statistical analysis was done by Med Calc software. Results: Distribution of CC genotype in cancer and control groups was,44 and 62.5, tespectively and distribution of CT genotype in cancer and control groups was 56 and 37.5, respectively, In the statistical analysis, χ2 and p value were respectively, 5.4 and 0.01. There is a significant association between this polymorphism and lymph nodes involvement and presence of tumor larger than 2cm3 (respectively p= 0.005 and p = 0.03). The results of this study showed -1562 C> T polymorphism in MMP9 promoter is associated with stage II and higher stages of breast cancer in our population. Furthermore, CT genotype may increase the risk of lymph node metastasis and presence of tumor larger than 2 cm3 (OR= 4). Conclusion: According to the results of this study, MMP9 (-1562 C> T) polymorphism may be used as a biomarker for breast cancer prognosis. Although, to achieve more definitive results, it is necessary to examine a larger population.
first_indexed 2024-12-11T15:18:24Z
format Article
id doaj.art-d1cec1d66d064ec7ae333b0fe9955a07
institution Directory Open Access Journal
issn 1735-5338
2008-644X
language fas
last_indexed 2024-12-11T15:18:24Z
publishDate 2016-06-01
publisher Arak Medical University
record_format Article
series Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
spelling doaj.art-d1cec1d66d064ec7ae333b0fe9955a072022-12-22T01:00:28ZfasArak Medical UniversityMajallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk1735-53382008-644X2016-06-011934653Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of IranFatemeh Toroghi 0Farhad Mashayekhi1Vahid Montazeri 2Hamid Saeedi Saedi3MSc in Cell and Molecular Biology, Department of Biology, University of Guilan, Rasht, Iran.Professor in Cell and Developmental Biology, Department of Biology, University of Guilan, Rasht, Iran.Professor, Department of Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.Assistant Professor, Department of Oncology, Guilan University of Medical Sciences, Rasht, Iran.Abstract Background: MMP9, as a member of the MMPs family, codes a protein that is able to provide suitable infrastructures for the migration of cancer cells and angiogenesis within tumor. The aim of this study was to investigate the relationship between -1562 C> T polymorphism in MMP9 promoter and progression of breast cancer in northwest of Iran. Materials and Methods: In this case-control study, 187 females from northwest of Iran were involved. Polymorphism of interest was determined by PCR-RFLP method using enzyme PaeI and statistical analysis was done by Med Calc software. Results: Distribution of CC genotype in cancer and control groups was,44 and 62.5, tespectively and distribution of CT genotype in cancer and control groups was 56 and 37.5, respectively, In the statistical analysis, χ2 and p value were respectively, 5.4 and 0.01. There is a significant association between this polymorphism and lymph nodes involvement and presence of tumor larger than 2cm3 (respectively p= 0.005 and p = 0.03). The results of this study showed -1562 C> T polymorphism in MMP9 promoter is associated with stage II and higher stages of breast cancer in our population. Furthermore, CT genotype may increase the risk of lymph node metastasis and presence of tumor larger than 2 cm3 (OR= 4). Conclusion: According to the results of this study, MMP9 (-1562 C> T) polymorphism may be used as a biomarker for breast cancer prognosis. Although, to achieve more definitive results, it is necessary to examine a larger population.http://amuj.arakmu.ac.ir/article-1-4062-en.pdfCancerMMP9Polymorphism
spellingShingle Fatemeh Toroghi
Farhad Mashayekhi
Vahid Montazeri
Hamid Saeedi Saedi
Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
Cancer
MMP9
Polymorphism
title Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
title_full Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
title_fullStr Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
title_full_unstemmed Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
title_short Association between MMP9 Promoter Polymorphism and Breast Cancer Progression in Northwest of Iran
title_sort association between mmp9 promoter polymorphism and breast cancer progression in northwest of iran
topic Cancer
MMP9
Polymorphism
url http://amuj.arakmu.ac.ir/article-1-4062-en.pdf
work_keys_str_mv AT fatemehtoroghi associationbetweenmmp9promoterpolymorphismandbreastcancerprogressioninnorthwestofiran
AT farhadmashayekhi associationbetweenmmp9promoterpolymorphismandbreastcancerprogressioninnorthwestofiran
AT vahidmontazeri associationbetweenmmp9promoterpolymorphismandbreastcancerprogressioninnorthwestofiran
AT hamidsaeedisaedi associationbetweenmmp9promoterpolymorphismandbreastcancerprogressioninnorthwestofiran